PKCβ inhibitor 1 is primarily used in research to study the role of protein kinase C beta (PKCβ) in various cellular processes. It is applied in experiments to understand its effects on signaling pathways, particularly in conditions like cancer, diabetes, and cardiovascular diseases. By inhibiting PKCβ, researchers can explore its impact on cell proliferation, apoptosis, and angiogenesis. This compound is also utilized in drug development studies to evaluate its potential as a therapeutic agent for diseases where PKCβ activity is dysregulated. Additionally, it aids in deciphering the molecular mechanisms underlying PKCβ-related disorders, providing insights for targeted treatment strategies.